- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.08. | BMS bags first approval for myeloma CELMoD Zenbexus | ||
| 13.08. | FDA cites 'significant concerns' with ADC lymphoma trial | ||
| 13.08. | Which biotechs have raised new VC financing this week? | ||
| 13.08. | MFN affecting Swiss medicines access, says Interpharma | ||
| 13.08. | Lilly, PTC Therapeutics snap up bankrupt Sangamo's main assets | ||
| 13.08. | Google adds insulin resistance tracker to wearables | ||
| 13.08. | Skylark trials gene therapy for common form of child deafness | ||
| 13.08. | ICER says AZ's new hypertension drug too expensive | ||
| 12.08. | Insmed partners patient group on bronchiectasis study | ||
| 12.08. | Definium chalks up new phase 3 win for LSD-based therapy | ||
| 12.08. | Lilly sues over 'illegal sales' of obesity drug retatrutide | ||
| 12.08. | Another 340B lawsuit gets underway, in Illinois | ||
| 12.08. | SNIPR phage therapy clears MDR infection in first patient | ||
| 11.08. | Manufacturing issues mar ITM's radiopharma filing, says FDA | ||
| 11.08. | England close to eliminating hep C thanks to treatment drive | ||
| 11.08. | Trump order upturns federal childhood vaccines policy | ||
| 11.08. | UK is first European country to approve Lilly's Foundayo | ||
| 10.08. | Ex-BioNTech execs launch 'AI-native' cancer company | ||
| 10.08. | Tenax trounced by phase 3 heart failure readout | ||
| 10.08. | Jazz builds in epilepsy with $1.3bn Actio acquisition | ||
| 10.08. | Novo Nordisk partners Amazon on London AI hub | ||
| 10.08. | Alzheimer's patients 'not changing brain health behaviours' | ||
| 10.08. | Sobi adds rare lymphoma drug with $580m Innate tie-up | ||
| 10.08. | Quartet of biotechs join Nasdaq after stellar IPOs | ||
| 07.08. | TransThera's resistant biliary cancer drug cleared in China |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.